One year after the initial rush of popularity and media interest, Australia's own custom dentistry startup has come a long way. 

Though the media might have been quiet, the team at Oventus has been hard at work securing distribution rights and certifications for the gobal market. 

In their latest report, they reveal that they have partnered for global distribution with the world's largest dental prosthetic provider, Modern Dental Group.

The distribution plan is to be funded by the proceeds of their initial share placement, which raised $7 million AUD. 

"We are very pleased to have Modern Dental as our go to market partner and exclusive distributor in the US. Modern Dental has market leading positions in Europe and Australia, and a very strong presence in the US, servicing a quarter of all dentists, via its laboratory business Microdental," said Neil Anderson, CEO of Oventus.

"The manufacturing agreement with Modern Dental is also important, as it will enable us to scale up manufacturing for a global market, at a lower cost. Over the next few months we will be working closely with Modern Dental to put in place the systems, training and marketing to ready us to begin ramping up sales from the October quarter, with the US as the main area of focus initially." 

The company was initially working with the CSIRO from 2014 onwards to help create and test their product and, grow business.

Oventus, a Melbourne based company, was approached by the CSIRO in 2014 after dentist Chris Hart had an idea for a mouthguard that would help airflow bypass for any obstructions in a sleep apnoea sufferers airway.

Now, according to the report, it has made "significant progresss in the execution of its clinical trial program to advance the validation of its proprietary airway technology" in its appliance line, including:

  • A peer reviewed article on the O2Vent Mono has been accepted for publication by the Journal of Dental Sleep Medicine.
  • A Brisbane clinical trial assessing the value of mandibular advancement with the Oventus airway technology is fully recruited.
  • A Perth clinical trial examining the physiological effect of the Oventus airway is now underway.

As for the 3D-dentistry market as a whole, predictions show that the international market is ballooning, with revenue set to hit $3.7 billion by 2021.

Related news & editorials

  1. 16.03.2018
    by      In
    The Omron S8VK-S series is billed as one of the world’s most compact DIN rail power supplies, and so is ideal for smaller control panels. The compact body size enables side-by-side mounting, which enhances design flexibility and reduces installation area by 30% compared with previous Omron power... Read More
  2. 16.03.2018
    by      In
    Rittal Australia has confirmed its national distribution partnership with APS Industrial, the newly formed specialist electrical industrial and automation equipment distributor.
    APS Industrial includes the existing businesses of Ramelec and HiTech – two well established Australian distributors,... Read More
  3. 15.03.2018
    by      In
    At just 6mm wide by 106mm high, the PTCB electronic circuit breaker from Phoenix Contact provides space saving circuit protection.
    The smart device protects 24V DC loads against overloads and short circuits. It can be used as a stand-alone circuit breaker or combined with the company’s Clipline DIN... Read More
  4. 15.03.2018
    by      In
    The Yawei Nisshinbo HPE Series from Applied Machinery is the latest in servo-driven Turret Punch Presses, providing high-end performance and power savings. 
    A technology partnership between Yawei and Nisshinbo to produce these CNC turret punch presses has been a massive success.
    Using German made... Read More